研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2017 年的期刊文章 · 第 9 页
共 1233 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2017-08-30 到 2017-08-08。
按期刊、按主题看 →
SiM Survival Analysis · 发表于 2017-08-30
Sarah Flora Jonas, Cyprien Mbogning, Philippe Broët
摘要
Several tests have been recently implemented in the nonparametric comparison of current status survival data. However, they are not suited for the situation of crossing hazards. In this setting, we propose a new test specifically designed for crossing hazards alternatives. The proposed test is compared to classical implemented tests through simulations mimicking crossing hazards situations with various schemes of censoring. The results show that the proposed test has a correct type I error and generally outperforms the existing methods. The application of the proposed test on a real dataset on immunogenicity of interferon‐βamong multiple sclerosis patients highlights the interest of the proposed test.
SiM Clinical Trials · 发表于 2017-08-29
Eduard Molins, Erik Cobo, Jordi Ocaña
摘要
The usual approach to determine bioequivalence for highly variable drugs is scaled average bioequivalence, which is based on expanding the limits as a function of the within‐subject variability in the reference formulation. This requires separately estimating this variability and thus using replicated or semireplicated crossover designs. On the other hand, regulations also allow using common 2 × 2 crossover designs based on two‐stage adaptive approaches with sample size reestimation at an interim analysis. The choice between scaled or two‐stage designs is crucial and must be fully described in the protocol. Using Monte Carlo simulations, we show that both methodologies achieve comparable statistical power, though the scaled method usually requires less sample size, but at the expense of each subject being exposed more times to the treatments. With an adequate initial sample size (not too low, eg, 24 subjects), two‐stage methods are a flexible and efficient option to consider: They have enough power (eg, 80%) at the first stage for non‐highly variable drugs, and, if otherwise, they provide the opportunity to step up to a second stage that includes additional subjects.
Biometrics Genetics & Omics · 发表于 2017-08-29
Yi-Hui Zhou, J. S. Marron, Fred A. Wright
摘要
Summary: Genotype eigenvectors are widely used as covariates for control of spurious stratification in genetic association. Significance testing for the accompanying eigenvalues has typically been based on a standard Tracy–Widom limiting distribution for the largest eigenvalue, derived under white-noise assumptions. It is known that even modest local correlation among markers inflates the largest eigenvalues, even in the absence of true stratification. In addition, a few sample eigenvalues may be extreme, creating further complications in accurate testing. We explore several methods to identify appropriate null eigenvalue thresholds, while remaining sensitive to eigenvalues corresponding to population stratification. We introduce a novel block permutation approach, designed to produce an appropriate null eigenvalue distribution by eliminating long-range genomic correlation while preserving local correlation. We also propose a fast approach based on eigenvalue distribution modeling, using a simple fit criterion and the general Marčenko–Pastur equation under a simple discrete eigenvalue model. Block permutation and the model-based approach work well for pure simulations and for data resampled from the 1000 Genomes project. In contrast, we find that the standard approach of computing an “effective” number of markers does not perform well. The performance of the methods is also demonstrated for a motivating example from the International Cystic Fibrosis Consortium.
SiM Other · 发表于 2017-08-29
Laszlo Tothfalusi, Laszlo Endrenyi
摘要
The determination of the bioequivalence between highly variable drug products involves the evaluation of reference scaled average bioequivalence. The European and US regulatory authorities suggest different algorithms for the implementation of this approach. Both algorithms are based on approximations reflected in lower than the achievable power or higher than the nominal consumer risk of 5%. To overcome these deficiencies, a new class of algorithms, the so‐called Exact methods, was earlier introduced. However, their applicability was limited. We propose 2 modifications which make their computation simpler and also applicable with any study design. Four algorithms were evaluated in simulated 3‐period and 4‐period bioequivalence studies: Hyslop's approach recommended by the US FDA, the method of average bioequivalence with expanding limits requested by the European EMA, and 2 versions of the new Exact methods. At small sample sizes, the Exact methods had substantially higher statistical power than Hyslop's algorithm and had lower consumer risk than the method of average bioequivalence with expanding limits. Similarly to the Hyslop's algorithm, higher than 5% consumer risk was observed only with either unbalanced study design or with additional regulatory requirements. The improved Exact algorithms compare favorably with the alternative procedures. They are based on the bias correction method of Hedges. The recognition that the scaled difference statistics is measured with bias has important practical implications when results of pilot bioequivalence studies are evaluated and, at the same time, calls for the revision of the statistical theory of RSABE and its related methods.
SiM Spatial & Time Series · 发表于 2017-08-29
Maricela Cruz, Miriam Bender, Hernando Ombao
摘要
Current health policy calls for greater use of evidence‐based care delivery services to improve patient quality and safety outcomes. Care delivery is complex, with interacting and interdependent components that challenge traditional statistical analytic techniques, in particular, when modeling a time series of outcomes data that might be “interrupted” by a change in a particular method of health care delivery. Interrupted time series (ITS) is a robust quasi‐experimental design with the ability to infer the effectiveness of an intervention that accounts for data dependency. Current standardized methods for analyzing ITS data do not model changes in variation and correlation following the intervention. This is a key limitation since it is plausible for data variability and dependency to change because of the intervention. Moreover, present methodology either assumes a prespecified interruption time point with an instantaneous effect or removes data for which the effect of intervention is not fully realized. In this paper, we describe and develop a novel robust interrupted time series (robust‐ITS) model that overcomes these omissions and limitations. The robust‐ITS model formally performs inference on (1) identifying the change point; (2) differences in preintervention and postintervention correlation; (3) differences in the outcome variance preintervention and postintervention; and (4) differences in the mean preintervention and postintervention. We illustrate the proposed method by analyzing patient satisfaction data from a hospital that implemented and evaluated a new nursing care delivery model as the intervention of interest. The robust‐ITS model is implemented in an R Shiny toolbox, which is freely available to the community.
Biometrics Survival Analysis · 发表于 2017-08-29
Fan Wu, Sehee Kim, Jing Qin, Rajiv Saran, Yi Li
摘要
Summary: Survival data collected from a prevalent cohort are subject to left truncation and the analysis is challenging. Conditional approaches for left-truncated data could be inefficient as they ignore the information in the marginal likelihood of the truncation times. Length-biased sampling methods may improve the estimation efficiency but only when the underlying truncation time is uniform; otherwise, they may generate biased estimates. We propose a semiparametric method for left-truncated data under the Cox model with no parametric distributional assumption about the truncation times. Our approach is to make inference based on the conditional likelihood augmented with a pairwise likelihood, which eliminates the truncation distribution, yet retains the information about the regression coefficients and the baseline hazard function in the marginal likelihood. An iterative algorithm is provided to solve for the regression coefficients and the baseline hazard function simultaneously. By empirical process and U-process theories, it has been shown that the proposed estimator is consistent and asymptotically normal with a closed-form consistent variance estimator. Simulation studies show substantial efficiency gain of our estimator in both the regression coefficients and the cumulative baseline hazard function over the conditional approach estimator. When the uniform truncation assumption holds, our estimator enjoys smaller biases and efficiency comparable to that of the full maximum likelihood estimator. An application to the analysis of a chronic kidney disease cohort study illustrates the utility of the method.
SiM Causal Inference Bayesian Methods · 发表于 2017-08-28
John R. Thompson, Cosetta Minelli, Jack Bowden, Fabiola M. Del Greco, Dipender Gill, Elinor M. Jones, Chin Yang Shapland, Nuala A. Sheehan
摘要
Mendelian randomization (MR) requires strong assumptions about the genetic instruments, of which the most difficult to justify relate to pleiotropy. In a two‐sample MR, different methods of analysis are available if we are able to assume,M1: no pleiotropy (fixed effects meta‐analysis),M2: that there may be pleiotropy but that the average pleiotropic effect is zero (random effects meta‐analysis), andM3: that the average pleiotropic effect is nonzero (MR‐Egger). In the latter 2 cases, we also require that the size of the pleiotropy is independent of the size of the effect on the exposure. Selecting one of these models without good reason would run the risk of misrepresenting the evidence for causality. The most conservative strategy would be to useM3in all analyses as this makes the weakest assumptions, but such an analysis gives much less precise estimates and so should be avoided whenever stronger assumptions are credible. We consider the situation of a two‐sample design when we are unsure which of these 3 pleiotropy models is appropriate. The analysis is placed within a Bayesian framework and Bayesian model averaging is used. We demonstrate that even large samples of the scale used in genome‐wide meta‐analysis may be insufficient to distinguish the pleiotropy models based on the data alone. Our simulations show that Bayesian model averaging provides a reasonable trade‐off between bias and precision. Bayesian model averaging is recommended whenever there is uncertainty about the nature of the pleiotropy.
SiM Clinical Trials · 发表于 2017-08-28
Chien‐Ju Lin, James M.S. Wason
摘要
In many phase II trials in solid tumours, patients are assessed using endpoints based on the Response Evaluation Criteria in Solid Tumours (RECIST) scale. Often, analyses are based on the response rate. This is the proportion of patients who have an observed tumour shrinkage above a predefined level and no new tumour lesions. The augmented binary method has been proposed to improve the precision of the estimator of the response rate. The method involves modelling the tumour shrinkage to avoid dichotomising it. However, in many trials the best observed response is used as the primary outcome. In such trials, patients are followed until progression, and their best observed RECIST outcome is used as the primary endpoint. In this paper, we propose a method that extends the augmented binary method so that it can be used when the outcome is best observed response. We show through simulated data and data from a real phase II cancer trial that this method improves power in both single‐arm and randomised trials. The average gain in power compared to the traditional analysis is equivalent to approximately a 35% increase in sample size. A modified version of the method is proposed to reduce the computational effort required. We show this modified method maintains much of the efficiency advantages.
SMMR Bayesian Methods Nonparametric & Semiparametric Spatial & Time Series · 发表于 2017-08-28
T Goicoa, A Adin, J Etxeberria, AF Militino, MD Ugarte
摘要
In this paper age–space–time models based on one and two-dimensional P-splines with B-spline bases are proposed for smoothing mortality rates, where both fixed relative scale and scale invariant two-dimensional penalties are examined. Model fitting and inference are carried out using integrated nested Laplace approximations, a recent Bayesian technique that speeds up computations compared to McMC methods. The models will be illustrated with Spanish breast cancer mortality data during the period 1985–2010, where a general decline in breast cancer mortality has been observed in Spanish provinces in the last decades. The results reveal that mortality rates for the oldest age groups do not decrease in all provinces.
SMMR Survival Analysis Networks & Graphs Nonparametric & Semiparametric · 发表于 2017-08-24
Hoora Moradian, Denis Larocque, François Bellavance
摘要
Tree-based methods are very powerful and popular tools for analysing survival data with right-censoring. The existing methods assume that the true time-to-event and the censoring times are independent given the covariates. We propose different ways to build survival forests when dependent censoring is suspected, by using an appropriate estimator of the survival function when aggregating the individual trees and/or by modifying the splitting rule. The appropriate estimator used in this paper is the copula-graphic estimator. We also propose a new method for building survival forests, called p-forest, that may be used not only when dependent censoring is suspected, but also as a new survival forest method in general. The results from a simulation study indicate that these modifications improve greatly the estimation of the survival function in situations of dependent censoring. A real data example illustrates how the proposed methods can be used to perform a sensitivity analysis.
SMMR Causal Inference Survival Analysis Missing Data & Measurement Error · 发表于 2017-08-24
Rebecca M Burne, Michal Abrahamowicz
摘要
Large databases used in observational studies of drug safety often lack information on important confounders. The resulting unmeasured confounding bias may be avoided by using additional confounder information, frequently available in smaller clinical “validation samples”. Yet, no existing method that uses such validation samples is able to deal with unmeasured time-varying variables acting as both confounders and possible mediators of the treatment effect. We propose and compare alternative methods which control for confounders measured only in a validation sample within marginal structural Cox models. Each method corrects the time-varying inverse probability of treatment weights for all subject-by-time observations using either regression calibration of the propensity score, or multiple imputation of unmeasured confounders. Two proposed methods rely on martingale residuals from a Cox model that includes only confounders fully measured in the large database, to correct inverse probability of treatment weight for imputed values of unmeasured confounders. Simulation demonstrates that martingale residual-based methods systematically reduce confounding bias over naïve methods, with multiple imputation including the martingale residual yielding, on average, the best overall accuracy. We apply martingale residual-based imputation to re-assess the potential risk of drug-induced hypoglycemia in diabetic patients, where an important laboratory test is repeatedly measured only in a small sub-cohort.
Biometrics Spatial & Time Series · 发表于 2017-08-23
Murray G. Efford, Christine M. Hunter
摘要
Summary: Sightings of previously marked animals can extend a capture–recapture dataset without the added cost of capturing new animals for marking. Combined marking and resighting methods are therefore an attractive option in animal population studies, and there exist various likelihood-based non-spatial models, and some spatial versions fitted by Markov chain Monte Carlo sampling. As implemented to date, the focus has been on modeling sightings only, which requires that the spatial distribution of pre-marked animals is known. We develop a suite of likelihood-based spatial mark–resight models that either include the marking phase (“capture–mark–resight” models) or require a known distribution of marked animals (narrow-sense “mark–resight”). The new models sacrifice some information in the covariance structure of the counts of unmarked animals; estimation is by maximizing a pseudolikelihood with a simulation-based adjustment for overdispersion in the sightings of unmarked animals. Simulations suggest that the resulting estimates of population density have low bias and adequate confidence interval coverage under typical sampling conditions. Further work is needed to specify the conditions under which ignoring covariance results in unacceptable loss of precision, or to modify the pseudolikelihood to include that information. The methods are applied to a study of ship rats Rattus rattus using live traps and video cameras in a New Zealand forest, and to previously published data.
SiM Survival Analysis · 发表于 2017-08-22
Kristin Ohneberg, Martin Schumacher, Jan Beyersmann
摘要
Competing risks extend standard survival analysis to considering time‐to‐first‐event and type‐of‐first‐event, where the event types are called competing risks. The competing risks process is completely described by all cause‐specific hazards, ie, the hazard marked by the event type. Separate Cox models for each cause‐specific hazard are the standard approach to regression modelling, but they come with the interpretational challenge that there are as many regression coefficients as there are competing risks. An alternative approach is to directly model the cumulative event probabilities, but again, there will be as many models as there are competing risks. The aim of this paper is to investigate the usefulness of a third alternative. Proportional odds modelling of all cause‐specific hazards summarizes the effect of one covariate on “opposing” competing outcomes in one regression coefficient. For instance, if the competing outcomes are hospital death and alive discharge from hospital, the modelling assumption is that a covariate affects both outcomes in opposing directions, but the effect size is of the same absolute magnitude. We will investigate the interpretational aspects of the approach analysing a data set on intensive care unit patients using parametric methods.
SMMR Missing Data & Measurement Error Survival Analysis · 发表于 2017-08-22
Folefac D Atem, Emmanuel Sampene, Thomas J Greene
摘要
This article describes a nonparametric conditional imputation analytic method for randomly censored covariates in linear regression. While some existing methods make assumptions about the distribution of covariates or underestimate standard error due to lack of imputation error, the proposed approach is distribution-free and utilizes resampling to correct for variance underestimation. The performance of the novel method is assessed using simulations, and results are contrasted with methods currently used for a limit of detection censored design, including the complete case approach and other nonparametric approaches. Theoretical justifications for the proposed method are provided, and its application is demonstrated through a study of association between lipoprotein cholesterol in offspring and parental history of cardiovascular disease.
SiM Longitudinal Data Bayesian Methods · 发表于 2017-08-22
O.D. Buhule, A.S. Wahed, A.O. Youk
摘要
Modeling of correlated biomarkers jointly has been shown to improve the efficiency of parameter estimates, leading to better clinical decisions. In this paper, we employ a joint modeling approach to a unique diabetes dataset, where blood glucose (continuous) and urine glucose (ordinal) measures of disease severity for diabetes are known to be correlated. The postulated joint model assumes that the outcomes are from distributions that are in the exponential family and hence modeled as multivariate generalized linear mixed effects model associated through correlated and/or shared random effects. The Markov chain Monte Carlo Bayesian approach is used to approximate posterior distribution and draw inference on the parameters. This proposed methodology provides a flexible framework to account for the hierarchical structure of the highly unbalanced data as well as the association between the 2 outcomes. The results indicate improved efficiency of parameter estimates when blood glucose and urine glucose are modeled jointly. Moreover, the simulation studies show that estimates obtained from the joint model are consistently less biased and more efficient than those in the separate models.
Biometrics Other · 发表于 2017-08-21
not listed
摘要
The Biometric Society was founded 70 years ago, officially formed on September 6, 1947, with a mission to promote the development and application of statistical and mathematical theory and methods in the biosciences, including agriculture, biomedical science and public health, ecology, environmental sciences, forestry, and allied disciplines.In 70 years, the Society has come a long way.Now, the International Biometric Society (IBS) is a worldwide society with almost 6000 members from over 70 different countries.The Society contains 35 recognized Regions, and four inter-regional Networks.Over half of IBS Regions represent members from developing countries. Biometry:the active pursuit of biological knowledge by quantitative methods (Fisher, 1948) 2017 Statement of the Society:The International Biometric Society cherishes the diversity of our membership, who represent over 70 different countries, with a wide range of ethnic, cultural and religious heritages.Any differences are transcended through our shared interest in statistical and mathematical methods for the biosciences.Our different perspectives challenge each other and bring greater depth to our work.Intellectual exchange within our society is fostered by the meetings that are routinely held by the various regions that make up our Society, as well as our biennial International Biometric Conference.The Society places the highest priority on our members' freedom to attend such meetings and to engage with each other on a global scale.As we celebrate the 70th birthday of the IBS and its ethnic, gender, geographic, and disciplinary diversity, we celebrate also the two scientific journals of the Society: Biometrics and JABES, which are the outward face of the Society and support the IBS mission to promote quantitative biosciences education and research capacity building worldwide. *(abstract via OpenAlex)*
SiM Survival Analysis · 发表于 2017-08-18
Wei Fu, Jeffrey S. Simonoff
摘要
Interval‐censored data, in which the event time is only known to lie in some time interval, arise commonly in practice, for example, in a medical study in which patients visit clinics or hospitals at prescheduled times and the events of interest occur between visits. Such data are appropriately analyzed using methods that account for this uncertainty in event time measurement. In this paper, we propose a survival tree method for interval‐censored data based on the conditional inference framework. Using Monte Carlo simulations, we find that the tree is effective in uncovering underlying tree structure, performs similarly to an interval‐censored Cox proportional hazards model fit when the true relationship is linear, and performs at least as well as (and in the presence of right‐censoring outperforms) the Cox model when the true relationship is not linear. Further, the interval‐censored tree outperforms survival trees based on imputing the event time as an endpoint or the midpoint of the censoring interval. We illustrate the application of the method on tooth emergence data.
SiM Clinical Trials Causal Inference · 发表于 2017-08-18
Joseph Antonelli, Bing Han, Matthew Cefalu
摘要
A critical issue in the analysis of clinical trials is patients' noncompliance to assigned treatments. In the context of a binary treatment with all or nothing compliance, the intent‐to‐treat analysis is a straightforward approach to estimating the effectiveness of the trial. In contrast, there exist 3 commonly used estimators with varying statistical properties for the efficacy of the trial, formally known as the complier‐average causal effect. The instrumental variable estimator may be unbiased but can be extremely variable in many settings. The as treated and per protocol estimators are usually more efficient than the instrumental variable estimator, but they may suffer from selection bias. We propose a synthetic approach that incorporates all 3 estimators in a data‐driven manner. The synthetic estimator is a linear convex combination of the instrumental variable, per protocol, and as treated estimators, resembling the popular model‐averaging approach in the statistical literature. However, our synthetic approach is nonparametric; thus, it is applicable to a variety of outcome types without specific distributional assumptions. We also discuss the construction of the synthetic estimator using an analytic form derived from a simple normal mixture distribution. We apply the synthetic approach to a clinical trial for post‐traumatic stress disorder.
SiM Longitudinal Data Nonparametric & Semiparametric Survival Analysis · 发表于 2017-08-17
Zhigang Li, H.R. Frost, Tor D. Tosteson, Lihui Zhao, Lei Liu, Kathleen Lyons, Huaihou Chen, Bernard Cole, David Currow, Marie Bakitas
摘要
Palliative medicine is an interdisciplinary specialty focusing on improving quality of life (QOL) for patients with serious illness and their families. Palliative care programs are available or under development at over 80% of large US hospitals (300+ beds). Palliative care clinical trials present unique analytic challenges relative to evaluating the palliative care treatment efficacy which is to improve patients’ diminishing QOL as disease progresses towards end of life (EOL). A unique feature of palliative care clinical trials is that patients will experience decreasing QOL during the trial despite potentially beneficial treatment. Often longitudinal QOL and survival data are highly correlated which, in the face of censoring, makes it challenging to properly analyze and interpret terminal QOL trend. To address these issues, we propose a novel semiparametric statistical approach to jointly model the terminal trend of QOL and survival data. There are two sub‐models in our approach: a semiparametric mixed effects model for longitudinal QOL and a Cox model for survival. We use regression splines method to estimate the nonparametric curves and AIC to select knots. We assess the model performance through simulation to establish a novel modeling approach that could be used in future palliative care research trials. Application of our approach in a recently completed palliative care clinical trial is also presented.
SMMR Missing Data & Measurement Error Latent Variables & Mixtures Clinical Trials · 发表于 2017-08-17
Xiaonan Xue, Maja Oktay, Sumanta Goswami, Mimi Y Kim
摘要
The paper is motivated by the problem of comparing the accuracy of two molecular tests in detecting genetic mutations in tumor samples when there is no gold standard test. Commonly used sequencing methods require a large number of tumor cells in the tumor sample and the proportion of tumor cells with mutation positivity to be above a threshold level whereas new tests aim to reduce the requirement for number of tumor cells and the threshold level. A new latent class model is proposed to compare these two tests in which a random variable is used to represent the unobserved proportion of mutation positivity so that these two tests are conditionally dependent; furthermore, an independent random variable is included to address measurement error associated with the reading from each test, while existing latent class models often assume conditional independence and do not allow measurement error. In addition, methods for calculating the sample size for a study that is sufficiently powered to compare the accuracy of two molecular tests are proposed and compared. The proposed methods are then applied to a study which aims to compare two molecular tests for detecting EGFR mutations in lung cancer patients.
SiM Testing & Uncertainty · 发表于 2017-08-16
Jana Timkova, Lukas Kotik, Ladislav Tomasek
摘要
This paper assesses the coverage probability of commonly used confidence intervals for the standardized mortality ratio (SMR) when death certificates are missing. It also proposes alternative confidence interval approaches with coverage probabilities close to .95. In epidemiology, the SMR is an important measure of risk of disease mortality (or incidence) to compare a specific group to a reference population. The appropriate confidence interval for the SMR is crucial, especially when the SMR is close to 1.0 and the statistical significance of the risk needs to be determined. There are several ways to calculate confidence intervals, depending on a study characteristics (ie, studies with small number of deaths, studies with small counts, aggregate SMRs based on several countries or time periods, and studies with missing death certificates). This paper summarizes the most commonly used confidence intervals and newly applies several existing approaches not previously used for SMR confidence intervals. The coverage probability and length of the different confidence intervals are assessed using a simulation study and different scenarios. The performance of the confidence intervals for the lung cancer SMR and all other cancer SMR is also assessed using the dataset of French and Czech uranium miners. Finally, the most appropriate confidence intervals to use under different study scenarios are recommended.
SiM Meta-Analysis & Data Integration Diagnostics & Prediction · 发表于 2017-08-16
Daisuke Yoneoka, Masayuki Henmi
摘要
Recently, the number of clinical prediction models sharing the same regression task has increased in the medical literature. However, evidence synthesis methodologies that use the results of these regression models have not been sufficiently studied, particularly in meta‐analysis settings where only regression coefficients are available. One of the difficulties lies in the differences between the categorization schemes of continuous covariates across different studies. In general, categorization methods using cutoff values are study specific across available models, even if they focus on the same covariates of interest. Differences in the categorization of covariates could lead to serious bias in the estimated regression coefficients and thus in subsequent syntheses. To tackle this issue, we developed synthesis methods for linear regression models with different categorization schemes of covariates. A 2‐step approach to aggregate the regression coefficient estimates is proposed. The first step is to estimate the joint distribution of covariates by introducing a latent sampling distribution, which uses one set of individual participant data to estimate the marginal distribution of covariates with categorization. The second step is to use a nonlinear mixed‐effects model with correction terms for the bias due to categorization to estimate the overall regression coefficients. Especially in terms of precision, numerical simulations show that our approach outperforms conventional methods, which only use studies with common covariates or ignore the differences between categorization schemes. The method developed in this study is also applied to a series of WHO epidemiologic studies on white blood cell counts.
SMMR Diagnostics & Prediction · 发表于 2017-08-16
Scott Powers, Valerie McGuire, Leslie Bernstein, Alison J Canchola, Alice S Whittemore
摘要
Personal predictive models for disease development play important roles in chronic disease prevention. The performance of these models is evaluated by applying them to the baseline covariates of participants in external cohort studies, with model predictions compared to subjects' subsequent disease incidence. However, the covariate distribution among participants in a validation cohort may differ from that of the population for which the model will be used. Since estimates of predictive model performance depend on the distribution of covariates among the subjects to which it is applied, such differences can cause misleading estimates of model performance in the target population. We propose a method for addressing this problem by weighting the cohort subjects to make their covariate distribution better match that of the target population. Simulations show that the method provides accurate estimates of model performance in the target population, while un-weighted estimates may not. We illustrate the method by applying it to evaluate an ovarian cancer prediction model targeted to US women, using cohort data from participants in the California Teachers Study. The methods can be implemented using open-source code for public use as the R-package RMAP (Risk Model Assessment Package) available at http://stanford.edu/~ggong/rmap/ .
SiM Testing & Uncertainty · 发表于 2017-08-16
Maria Petropoulou, Dimitris Mavridis
摘要
When we synthesize research findings via meta‐analysis, it is common to assume that the true underlying effect differs across studies. Total variability consists of the within‐study and between‐study variances (heterogeneity). There have been established measures, such as I2, to quantify the proportion of the total variation attributed to heterogeneity. There is a plethora of estimation methods available for estimating heterogeneity. The widely used DerSimonian and Laird estimation method has been challenged, but knowledge of the overall performance of heterogeneity estimators is incomplete. We identified 20 heterogeneity estimators in the literature and evaluated their performance in terms of mean absolute estimation error, coverage probability, and length of the confidence interval for the summary effect via a simulation study. Although previous simulation studies have suggested the Paule‐Mandel estimator, it has not been compared with all the available estimators. For dichotomous outcomes, estimating heterogeneity through Markov chain Monte Carlo is a good choice if an informative prior distribution for heterogeneity is employed (eg, by published Cochrane reviews). Nonparametric bootstrap and positive DerSimonian and Laird perform well for all assessment criteria for both dichotomous and continuous outcomes. Hartung‐Makambi estimator can be the best choice when the heterogeneity values are close to 0.07 for dichotomous outcomes and medium heterogeneity values (0.01 , 0.05) for continuous outcomes. Hence, there are heterogeneity estimators (nonparametric bootstrap DerSimonian and Laird and positive DerSimonian and Laird) that perform better than the suggested Paule‐Mandel. Maximum likelihood provides the best performance for both types of outcome in the absence of heterogeneity.
SiM Clinical Trials Survival Analysis · 发表于 2017-08-16
Milind A. Phadnis, James B. Wetmore, Matthew S. Mayo
摘要
Traditional methods of sample size and power calculations in clinical trials with a time‐to‐event end point are based on the logrank test (and its variations), Cox proportional hazards (PH) assumption, or comparison of means of 2 exponential distributions. Of these, sample size calculation based on PH assumption is likely the most common and allows adjusting for the effect of one or more covariates. However, when designing a trial, there are situations when the assumption of PH may not be appropriate. Additionally, when it is known that there is a rapid decline in the survival curve for a control group, such as from previously conducted observational studies, a design based on the PH assumption may confer only a minor statistical improvement for the treatment group that is neither clinically nor practically meaningful. For such scenarios, a clinical trial design that focuses on improvement in patient longevity is proposed, based on the concept of proportional time using the generalized gamma ratio distribution. Simulations are conducted to evaluate the performance of the proportional time method and to identify the situations in which such a design will be beneficial as compared to the standard design using a PH assumption, piecewise exponential hazards assumption, and specific cases of a cure rate model. A practical example in which hemorrhagic stroke patients are randomized to 1 of 2 arms in a putative clinical trial demonstrates the usefulness of this approach by drastically reducing the number of patients needed for study enrollment.
SiM Diagnostics & Prediction · 发表于 2017-08-15
Hani M. Samawi, Jingjing Yin, Haresh Rochani, Viral Panchal
摘要
The receiver operating characteristic (ROC) curve is frequently used to evaluate and compare diagnostic tests. As one of the ROC summary indices, the Youden index measures the effectiveness of a diagnostic marker and enables the selection of an optimal threshold value (cut‐off point) for the marker. Recently, the overlap coefficient, which captures the similarity between 2 distributions directly, has been considered as an alternative index for determining the diagnostic performance of markers. In this case, a larger overlap indicates worse diagnostic accuracy, and vice versa. This paper provides a graphical demonstration and mathematical derivation of the relationship between the Youden index and the overlap coefficient and states their advantages over the most popular diagnostic measure, the area under the ROC curve. Furthermore, we outline the differences between the Youden index and overlap coefficient and identify situations in which the overlap coefficient outperforms the Youden index. Numerical examples and real data analysis are provided.
SiM Causal Inference Survival Analysis Longitudinal Data · 发表于 2017-08-15
Sheng‐Hsuan Lin, Jessica G. Young, Roger Logan, Tyler J. VanderWeele
摘要
We propose an approach to conduct mediation analysis for survival data with time‐varying exposures, mediators, and confounders. We identify certain interventional direct and indirect effects through a survival mediational g‐formula and describe the required assumptions. We also provide a feasible parametric approach along with an algorithm and software to estimate these effects. We apply this method to analyze the Framingham Heart Study data to investigate the causal mechanism of smoking on mortality through coronary artery disease. The estimated overall 10‐year all‐cause mortality risk difference comparing “always smoke 30 cigarettes per day” versus “never smoke” was 4.3 (95% CI = (1.37, 6.30)). Of the overall effect, we estimated 7.91% (95% CI: = 1.36%, 19.32%) was mediated by the incidence and timing of coronary artery disease. The survival mediational g‐formula constitutes a powerful tool for conducting mediation analysis with longitudinal data.
Biometrics Meta-Analysis & Data Integration Networks & Graphs · 发表于 2017-08-14
Dan Jackson, Sylwia Bujkiewicz, Martin Law, Richard D. Riley, Ian R. White
摘要
Summary: Random-effects meta-analyses are very commonly used in medical statistics. Recent methodological developments include multivariate (multiple outcomes) and network (multiple treatments) meta-analysis. Here, we provide a new model and corresponding estimation procedure for multivariate network meta-analysis, so that multiple outcomes and treatments can be included in a single analysis. Our new multivariate model is a direct extension of a univariate model for network meta-analysis that has recently been proposed. We allow two types of unknown variance parameters in our model, which represent between-study heterogeneity and inconsistency. Inconsistency arises when different forms of direct and indirect evidence are not in agreement, even having taken between-study heterogeneity into account. However, the consistency assumption is often assumed in practice and so we also explain how to fit a reduced model which makes this assumption. Our estimation method extends several other commonly used methods for meta-analysis, including the method proposed by DerSimonian and Laird (1986). We investigate the use of our proposed methods in the context of both a simulation study and a real example.
SiM Longitudinal Data Survival Analysis Bayesian Methods · 发表于 2017-08-10
Getachew A. Dagne
摘要
In this article, we show how Tobit models can address problems of identifying characteristics of subjects having left‐censored outcomes in the context of developing a method for jointly analyzing time‐to‐event and longitudinal data. There are some methods for handling these types of data separately, but they may not be appropriate when time to event is dependent on the longitudinal outcome, and a substantial portion of values are reported to be below the limits of detection. An alternative approach is to develop a joint model for the time‐to‐event outcome and a two‐part longitudinal outcome, linking them through random effects. This proposed approach is implemented to assess the association between the risk of decline of CD4/CD8 ratio and rates of change in viral load, along with discriminating between patients who are potentially progressors to AIDS from patients who do not. We develop a fully Bayesian approach for fitting joint two‐part Tobit models and illustrate the proposed methods on simulated and real data from an AIDS clinical study.
SiM Longitudinal Data Bayesian Methods · 发表于 2017-08-10
Sophie Carles, Marie‐Aline Charles, Barbara Heude, Ismaïl Ahmed, Jérémie Botton, the EDEN mother‐child study group
摘要
Growth models used for describing the dynamics of body weight and height generally consider each trait independently. We proposed modeling height and weight trajectories jointly with a nonlinear heteroscedastic mixed model based on the Jenss‐Bayley growth function with correlated individual random effects and using Bayesian inference techniques. Simulations showed that our model provides good estimates of the growth parameters. We illustrated how it can be used to assess the associations between maternal smoking during pregnancy, an early‐life factor potentially involved in prenatal programming of obesity, and children's growth from birth to 5 years of age. We used real data from the EDEN study, a large French mother‐child cohort study with a high number of height and weight measurements (a total of approximately 30 000 measurements for each of the 2 traits across the 1666 children). Our results supported the existence of a relationship between maternal smoking during pregnancy and growth from birth to 5 years of age. Children from mothers who smoked throughout pregnancy were shown to display a higher body mass index from the first few months of life onwards compared to children from nonsmokers. At 5 years of age, their mean body mass index was 0.21 kg/m2 higher than unexposed children. It was mainly explained by the fact that these children tended to be smaller at birth but rapidly exceeded the weight of children from nonsmokers postnatally.
SiM Diagnostics & Prediction Clinical Trials · 发表于 2017-08-10
Richard Simon, Noah Simon
摘要
Identification of treatment selection biomarkers has become very important in cancer drug development. Adaptive enrichment designs have been developed for situations where a unique treatment selection biomarker is not apparent based on the mechanism of action of the drug. With such designs, the eligibility rules may be adaptively modified at interim analysis times to exclude patients who are unlikely to benefit from the test treatment.We consider a recently proposed, particularly flexible approach that permits development of model‐based multifeature predictive classifiers as well as optimized cut‐points for continuous biomarkers. A single significance test, including all randomized patients, is performed at the end of the trial of the strong null hypothesis that the expected outcome on the test treatment is no better than control for any of the subset populations of patients accrued in the K stages of the clinical trial. In this paper, we address 2 issues involving inference following an adaptive enrichment design as described above. The first is specification of the intended use population and estimation of treatment effect for that population following rejection of the strong null hypothesis. The second issue is defining conditions in which rejection of the strong null hypothesis implies rejection of the null hypothesis for the intended use population.
SMMR Other · 发表于 2017-08-10
Wenjun Xiong, Juan Ding, Yuanzhen He, Qizhai Li
摘要
Pooled testing is useful to identify positive specimens for large-scale screening. Matrix pooling is one of the commonly used algorithms. In this work, we investigate the properties of matrix pooling and reveal that the efficiency of matrix pooling is related with the magnitude of overlapping among groups. Based on this property, we develop a new design to further improve the efficiency while taking into account of testing error. The efficiency, pooling sensitivity and specificity of this algorithm are explicitly derived and verified through plasmode simulation of detecting acute human immunodeficiency virus among patients who were suspected to have malaria in rural Ugandan. We show that the new design outperforms matrix pooling in efficiency while retain the pooling sensitivity and specificity.
SiM Causal Inference · 发表于 2017-08-09
Alisa J. Stephens‐Shields, Andrew J. Spieker, Amanda Anderson, Paul Drawz, Michael Fischer, Stephen M. Sozio, Harold Feldman, Marshall Joffe, Wei Yang, Tom Greene, CRIC Study Investigators
摘要
In patients with chronic kidney disease (CKD), clinical interest often centers on determining treatments and exposures that are causally related to renal progression. Analyses of longitudinal clinical data in this population are often complicated by clinical competing events, such as end‐stage renal disease (ESRD) and death, and time‐dependent confounding, where patient factors that are predictive of later exposures and outcomes are affected by past exposures. We developed multistate marginal structural models (MS‐MSMs) to assess the effect of time‐varying systolic blood pressure on disease progression in subjects with CKD. The multistate nature of the model allows us to jointly model disease progression characterized by changes in the estimated glomerular filtration rate (eGFR), the onset of ESRD, and death, and thereby avoid unnatural assumptions of death and ESRD as noninformative censoring events for subsequent changes in eGFR. We model the causal effect of systolic blood pressure on the probability of transitioning into 1 of 6 disease states given the current state. We use inverse probability weights with stabilization to account for potential time‐varying confounders, including past eGFR, total protein, serum creatinine, and hemoglobin. We apply the model to data from the Chronic Renal Insufficiency Cohort Study, a multisite observational study of patients with CKD.
Biometrika High-Dimensional Testing & Uncertainty · 发表于 2017-08-08
Qing Zhou, Seunghyun Min
摘要
Quantifying the uncertainty in penalized regression under group sparsity is an important open question. We establish, under a high-dimensional scaling, the asymptotic validity of a modified parametric bootstrap method for the group lasso, assuming a Gaussian error model and mild conditions on the design matrix and the true coefficients. Simulation of bootstrap samples provides simultaneous inferences on large groups of coefficients. Through extensive numerical comparisons, we demonstrate that our bootstrap method performs much better than popular competitors, highlighting its practical utility. The theoretical results generalize to other block norm penalization and sub-Gaussian errors, which further broadens the potential applications. *(abstract via OpenAlex)*
SiM Survival Analysis Clinical Trials Causal Inference · 发表于 2017-08-08
Suhyun Kang, Wenbin Lu, Rui Song
摘要
In this paper, we propose a testing procedure for detecting and estimating the subgroup with an enhanced treatment effect in survival data analysis. Here, we consider a new proportional hazard model that includes a nonparametric component for the covariate effect in the control group and a subgroup‐treatment–interaction effect defined by a change plane. We develop a score‐type test for detecting the existence of the subgroup, which is doubly robust against misspecification of the baseline effect model or the propensity score but not both under mild assumptions for censoring. When the null hypothesis of no subgroup is rejected, the change‐plane parameters that define the subgroup can be estimated on the basis of supremum of the normalized score statistic. The asymptotic distributions of the proposed test statistic under the null and local alternative hypotheses are established. On the basis of established asymptotic distributions, we further propose a sample size calculation formula for detecting a given subgroup effect and derive a numerical algorithm for implementing the sample size calculation in clinical trial designs. The performance of the proposed approach is evaluated by simulation studies. An application to an AIDS clinical trial data is also given for illustration.
SiM Clinical Trials Causal Inference Longitudinal Data · 发表于 2017-08-08
J. N. S. Matthews, A. B. Forbes
摘要
Stepped wedge designs (SWDs) have received considerable attention recently, as they are potentially a useful way to assess new treatments in areas such as health services implementation. Because allocation is usually by cluster, SWDs are often viewed as a form of cluster‐randomized trial. However, since the treatment within a cluster changes during the course of the study, they can also be viewed as a form of crossover design. This article explores SWDs from the perspective of crossover trials and designed experiments more generally. We show that the treatment effect estimator in a linear mixed effects model can be decomposed into a weighted mean of the estimators obtained from (1) regarding an SWD as a conventional row‐column design and (2) a so‐called vertical analysis, which is a row‐column design with row effects omitted. This provides a precise representation of “horizontal” and “vertical” comparisons, respectively, which to date have appeared without formal description in the literature. This decomposition displays a sometimes surprising way the analysis corrects for the partial confounding between time and treatment effects. The approach also permits the quantification of the loss of efficiency caused by mis‐specifying the correlation parameter in the mixed‐effects model. Optimal extensions of the vertical analysis are obtained, and these are shown to be highly inefficient for values of the within‐cluster dependence that are likely to be encountered in practice. Some recently described extensions to the classic SWD incorporating multiple treatments are also compared using the experimental design framework.